Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Genetic determinants of plasma lipoproteins.

Pollex RL, Hegele RA.

Nat Clin Pract Cardiovasc Med. 2007 Nov;4(11):600-9. Review.

PMID:
17957207
2.

A treasure trove for lipoprotein biology.

Lusis AJ, Pajukanta P.

Nat Genet. 2008 Feb;40(2):129-30. doi: 10.1038/ng0208-129. No abstract available.

PMID:
18227868
3.

The genetic basis of lipoprotein disorders. Introduction and overview.

Breslow JL.

J Intern Med. 1992 Jun;231(6):627-31.

PMID:
1535651
4.

Genomic copy number variation and its potential role in lipoprotein and metabolic phenotypes.

Pollex RL, Hegele RA.

Curr Opin Lipidol. 2007 Apr;18(2):174-80. Review.

PMID:
17353666
5.

Genetic determinants of HDL: monogenic disorders and contributions to variation.

Klos KL, Kullo IJ.

Curr Opin Cardiol. 2007 Jul;22(4):344-51. Review.

PMID:
17556888
6.

The genetic determinants of plasma cholesterol and response to diet.

Humphries SE, Peacock RE, Talmud PJ.

Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):797-823. Review.

PMID:
8593126
7.

Common lipid-altering gene variants are associated with therapeutic intervention thresholds of lipid levels in older people.

Murray A, Cluett C, Bandinelli S, Corsi AM, Ferrucci L, Guralnik J, Singleton A, Frayling T, Melzer D.

Eur Heart J. 2009 Jul;30(14):1711-9. doi: 10.1093/eurheartj/ehp161. Epub 2009 May 12.

8.

Variation of candidate genes in triglyceride metabolism.

Busch CP, Hegele RA.

J Cardiovasc Risk. 2000 Oct;7(5):309-15. Review.

PMID:
11143760
9.

Inconsistencies in the genetic prediction of HDL cholesterol versus atherosclerosis.

Carlquist J, Anderson JL.

Curr Opin Cardiol. 2007 Jul;22(4):352-8. Review.

PMID:
17556889
10.

Analysis of family resemblance for lipids and lipoproteins.

Iselius L.

Clin Genet. 1979 Apr;15(4):300-6.

PMID:
436327
11.
12.

Defining the spectrum of alleles that contribute to blood lipid concentrations in humans.

Kathiresan S, Musunuru K, Orho-Melander M.

Curr Opin Lipidol. 2008 Apr;19(2):122-7. doi: 10.1097/MOL.0b013e3282f70296. Review.

PMID:
18388691
13.

[Molecular mechanism of fatty acids impact on plasma lipid profile (part I)].

Swierczyński J, Wołyniec W, Chmielewski M, Rutkowski B.

Przegl Lek. 2007;64(1):37-41. Review. Polish.

PMID:
18183830
14.
15.

Hypertriglyceridemia: phenomics and genomics.

Hegele RA, Pollex RL.

Mol Cell Biochem. 2009 Jun;326(1-2):35-43. doi: 10.1007/s11010-008-0005-1. Epub 2009 Jan 7.

PMID:
19130180
16.

The genetic basis of atherosclerosis.

Hegele RA.

Int J Clin Lab Res. 1997;27(1):2-13. Review.

PMID:
9144022
17.

[Analysis of lipoprotein metabolism in alcoholics].

Mizukami Y, Okazaki M, Usui S, Hosaki S, Maruyama K, Hosokawa Y.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008 Apr;43(2):110-9. Japanese.

PMID:
18516950
18.

Plasma lipoproteins: genetic influences and clinical implications.

Hegele RA.

Nat Rev Genet. 2009 Feb;10(2):109-21. doi: 10.1038/nrg2481. Epub 2009 Jan 13. Review.

PMID:
19139765
19.

Role of caveolin-1 in the regulation of lipoprotein metabolism.

Frank PG, Pavlides S, Cheung MW, Daumer K, Lisanti MP.

Am J Physiol Cell Physiol. 2008 Jul;295(1):C242-8. doi: 10.1152/ajpcell.00185.2008. Epub 2008 May 28.

20.

Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus.

Vrablík M, Dobiásová M, Stulc T, Kasalová Z, Dolezalová R, Prázný M, Fait T, Ceska R.

Neuro Endocrinol Lett. 2008 Feb;29(1):146-50.

PMID:
18283261

Supplemental Content

Support Center